AstraZeneca is making flu protection more convenient with the launch of an at-home delivery option for FluMist, its nasal spray flu vaccine, the company announced Friday.
On the market since 2003, FluMist was previously only available at pharmacies or doctors’ offices.
Beginning Friday, eligible customers can order it online and have it shipped directly to their door, allowing parents to vaccinate their children at home without shots or a trip to the pharmacy.
The spray can be self-administered by adults up to age 49, while caregivers can give it to children ages 2–17, the company said.
The FDA approved FluMist for self- and caregiver-administration in September 2024, after research showed adults over 18 could safely and effectively administer it to eligible individuals.
AstraZeneca hopes the needle-free option and at-home convenience will boost vaccination rates this year.
Last year’s flu season saw the highest number of flu-related deaths for children for a non-pandemic year — 267 — since the 2009 H1N1 pandemic, according to the Centers for Disease Control and Prevention. Health experts stress that vaccination remains the best protection against the virus, though getting kids vaccinated can be a challenge.
The CDC continues to recommend that everyone 6 months and older get a flu vaccine this fall.
Most health insurance plans are expected to cover the cost, with a shipping fee for four FluMist doses estimated at under $10.
The company added for those who qualify, the nasal spray offers safety and effectiveness comparable to traditional flu shots.
The post AstraZeneca launches at-home FluMist nasal spray delivery appeared first on ABC News.
